Quick Heal net profit grows 6% to Rs 14 crore in December quarter

Quick Heal Technologies said its consolidated net profit grew 6.1 per cent to Rs 14.3 crore in December quarter 2021.

cash, currency, notes, funds, investment, shares, growth, profit, loss, tax, money, income, earnings
Press Trust of India New Delhi
2 min read Last Updated : Jan 24 2022 | 9:46 PM IST

Security software provider Quick Heal Technologies on Monday said its consolidated net profit grew 6.1 per cent to Rs 14.3 crore in December quarter 2021.

The company had posted a net profit of Rs 13.5 crore in the year-ago period, Quick Heal said in a regulatory filing.

Total revenue rose 13.9 per cent to Rs 79.6 crore in the quarter under review, from Rs 69.9 crore in the year-ago period, it added.

We delivered a robust third quarter in terms of revenue, subscribers, profitability and cash flow which is a testament to our team's strong execution. Our continued commitment to secure our customers' ever-increasing online footprint helped us add 818,000 new subscribers," Managing Director and CEO Kailash Katkar said.

He added that the growth in enterprise segment has been promising and the company expects the momentum to continue in the coming quarters.

"In line with our strategy to boost market share, we continue to invest in R&D and strengthen leadership team that will enable us to launch next-generation solutions in the coming quarters, he said.

The company saw its retail segment revenue rise 8.1 per cent year-on-year to Rs 65.2 crore (from Rs 60.3 crore in the corresponding period of the previous year), while enterprise and government segment revenue was up 11.3 per cent year-on-year at Rs 20.1 crore in the quarter under review (from Rs 18 crore).

Chief Financial Officer Navin Sharma said,"We delivered solid results in Q3, as continued strong demand for our cybersecurity products across our diversified global go-to-market channels, coupled with our focus on operational discipline, resulted in 14 per cent y-o-y growth in revenue and 24 per cent y-o-y growth in EBITDA.

"In line with our continued focus on R&D and innovation, we spent 27 per cent of revenues as R&D during the quarter."

He added that the company's balance sheet remains strong with zero debt and cash and cash equivalents of Rs 327.5 crore as on December 31, 2021.

"We are committed to driving shareholder value by growing profitability across both of our segments and driving solid unlevered cash flow," he said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CompaniesQuick Heal Technologies

First Published: Jan 24 2022 | 9:46 PM IST

Next Story